Bay City Capital is a global life sciences investment firm that backs innovative companies across biotech, medical devices, digital health, and ag‑tech. They target founders with strong scientific platforms and scalable business models, providing capital from seed through later‑stage growth to accelerate product development and market adoption. Their diversified strategy leverages extensive industry expertise and a broad network to create long‑term value in health‑impacting technologies.
Industries
Industry breakdown
Top industries in the portfolio
Geography
Geographic scope
Global
Geography breakdown
Darker regions = more portfolio companies
Top 5 countries
United States of America
61.9%Bulgaria
4.8%Canada
4.8%Germany
4.8%Finland
4.8%Other
9.6%Countries with a higher share of the portfolio are shaded darker on the map.
Stages
Stage indicator
Seed → Series C+
Stage breakdown
Portfolio by stage
Portfolio vintage
Companies by founded year
Fund details
Funds
Fund V
$500M
Fund IV
$350M
Fund III
$250M
Fund II
$200M
Fund I
$150M